829 related articles for article (PubMed ID: 31391268)
21. TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells.
Bertram S; Glowacka I; Blazejewska P; Soilleux E; Allen P; Danisch S; Steffen I; Choi SY; Park Y; Schneider H; Schughart K; Pöhlmann S
J Virol; 2010 Oct; 84(19):10016-25. PubMed ID: 20631123
[TBL] [Abstract][Full Text] [Related]
22. Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation.
Meyer D; Sielaff F; Hammami M; Böttcher-Friebertshäuser E; Garten W; Steinmetzer T
Biochem J; 2013 Jun; 452(2):331-43. PubMed ID: 23527573
[TBL] [Abstract][Full Text] [Related]
23. Exchange of amino acids in the H1-haemagglutinin to H3 residues is required for efficient influenza A virus replication and pathology in Tmprss2 knock-out mice.
Lambertz RLO; Pippel J; Gerhauser I; Kollmus H; Anhlan D; Hrincius ER; Krausze J; Kühn N; Schughart K
J Gen Virol; 2018 Sep; 99(9):1187-1198. PubMed ID: 30084768
[TBL] [Abstract][Full Text] [Related]
24. TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1.
Zmora P; Hoffmann M; Kollmus H; Moldenhauer AS; Danov O; Braun A; Winkler M; Schughart K; Pöhlmann S
J Biol Chem; 2018 Sep; 293(36):13863-13873. PubMed ID: 29976755
[TBL] [Abstract][Full Text] [Related]
25. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation.
Galloway SE; Reed ML; Russell CJ; Steinhauer DA
PLoS Pathog; 2013 Feb; 9(2):e1003151. PubMed ID: 23459660
[TBL] [Abstract][Full Text] [Related]
26. Enterokinase Enhances Influenza A Virus Infection by Activating Trypsinogen in Human Cell Lines.
Hayashi H; Kubo Y; Izumida M; Takahashi E; Kido H; Sato K; Yamaya M; Nishimura H; Nakayama K; Matsuyama T
Front Cell Infect Microbiol; 2018; 8():91. PubMed ID: 29629340
[TBL] [Abstract][Full Text] [Related]
27. A mutant H3N2 influenza virus uses an alternative activation mechanism in TMPRSS2 knockout mice by loss of an oligosaccharide in the hemagglutinin stalk region.
Sakai K; Sekizuka T; Ami Y; Nakajima N; Kitazawa M; Sato Y; Nakajima K; Anraku M; Kubota T; Komase K; Takehara K; Hasegawa H; Odagiri T; Tashiro M; Kuroda M; Takeda M
J Virol; 2015 May; 89(9):5154-8. PubMed ID: 25673722
[TBL] [Abstract][Full Text] [Related]
28. Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium.
Böttcher-Friebertshäuser E; Klenk HD; Garten W
Pathog Dis; 2013 Nov; 69(2):87-100. PubMed ID: 23821437
[TBL] [Abstract][Full Text] [Related]
29. The hemagglutinin: a determinant of pathogenicity.
Böttcher-Friebertshäuser E; Garten W; Matrosovich M; Klenk HD
Curr Top Microbiol Immunol; 2014; 385():3-34. PubMed ID: 25031010
[TBL] [Abstract][Full Text] [Related]
30. Activation of influenza A viruses by host proteases from swine airway epithelium.
Peitsch C; Klenk HD; Garten W; Böttcher-Friebertshäuser E
J Virol; 2014 Jan; 88(1):282-91. PubMed ID: 24155384
[TBL] [Abstract][Full Text] [Related]
31. Expression of TMPRSS2 is up-regulated by bacterial flagellin, LPS, and Pam3Cys in human airway cells.
Schwerdtner M; Skalik A; Limburg H; Bierwagen J; Jung AL; Dorna J; Kaufmann A; Bauer S; Schmeck B; Böttcher-Friebertshäuser E
Life Sci Alliance; 2023 Aug; 6(8):. PubMed ID: 37208193
[TBL] [Abstract][Full Text] [Related]
32. Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice.
Hatesuer B; Bertram S; Mehnert N; Bahgat MM; Nelson PS; Pöhlmann S; Schughart K
PLoS Pathog; 2013; 9(12):e1003774. PubMed ID: 24348248
[TBL] [Abstract][Full Text] [Related]
33. SPINT2 inhibits proteases involved in activation of both influenza viruses and metapneumoviruses.
Straus MR; Kinder JT; Segall M; Dutch RE; Whittaker GR
Virology; 2020 Apr; 543():43-53. PubMed ID: 32056846
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of MHC Class I Expression by Influenza A and B Viruses.
Koutsakos M; McWilliam HEG; Aktepe TE; Fritzlar S; Illing PT; Mifsud NA; Purcell AW; Rockman S; Reading PC; Vivian JP; Rossjohn J; Brooks AG; Mackenzie JM; Mintern JD; Villadangos JA; Nguyen THO; Kedzierska K
Front Immunol; 2019; 10():1158. PubMed ID: 31191533
[TBL] [Abstract][Full Text] [Related]
35. Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses.
Baron J; Tarnow C; Mayoli-Nüssle D; Schilling E; Meyer D; Hammami M; Schwalm F; Steinmetzer T; Guan Y; Garten W; Klenk HD; Böttcher-Friebertshäuser E
J Virol; 2013 Feb; 87(3):1811-20. PubMed ID: 23192872
[TBL] [Abstract][Full Text] [Related]
36. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
[TBL] [Abstract][Full Text] [Related]
37. The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.
Yamaya M; Shimotai Y; Hatachi Y; Lusamba Kalonji N; Tando Y; Kitajima Y; Matsuo K; Kubo H; Nagatomi R; Hongo S; Homma M; Nishimura H
Pulm Pharmacol Ther; 2015 Aug; 33():66-74. PubMed ID: 26166259
[TBL] [Abstract][Full Text] [Related]
38. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium.
Böttcher E; Matrosovich T; Beyerle M; Klenk HD; Garten W; Matrosovich M
J Virol; 2006 Oct; 80(19):9896-8. PubMed ID: 16973594
[TBL] [Abstract][Full Text] [Related]
39. Role of host trypsin-type serine proteases and influenza virus-cytokine-trypsin cycle in influenza viral pathogenesis. Pathogenesis-based therapeutic options.
Kido H; Takahashi E; Kimoto T
Biochimie; 2019 Nov; 166():203-213. PubMed ID: 31518617
[TBL] [Abstract][Full Text] [Related]
40. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.
Kido H; Okumura Y; Yamada H; Le TQ; Yano M
Curr Pharm Des; 2007; 13(4):405-14. PubMed ID: 17311557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
